ORBIS BIOSCIENCES, INC.

Basic Information

2002 W 39th Ave
KANSAS CITY, KS, 66103-2943

Company Profile

n/a

Additional Details

Field Value
DUNS: 828536438
Hubzone Owned: N
Socially and Economically Disadvantaged: N
Woman Owned: N
Number of Employees: n/a


  1. Engineering Microparticles for Taste-Masking and Controlled Release of Pediatric

    Amount: $1,336,086.00

    DESCRIPTION (provided by applicant): New dosage forms are needed to address the shortcomings of current practice with regard to administration of medications to pediatric populations. Specifically, in ...

    SBIR Phase II 2014 Department of Health and Human Services
  2. Expanding Precision Particle Fabrication Technology for the Widespread Control of

    Amount: $1,698,318.00

    DESCRIPTION (provided by applicant): A critical need currently exists in the pharmaceutical market for microparticles that can accurately and effectively control the release of poorly water-soluble c ...

    SBIR Phase II 2013 Department of Health and Human Services
  3. Precision Particle Fabrication-enabled Betamethasone-loaded Microspheres for Tran

    Amount: $287,056.00

    DESCRIPTION (provided by applicant): Current approaches to treat sudden sensorineural hearing loss (SSNHL) do not maintain inner ear drug concentrations within an appropriate therapeutic window for su ...

    SBIR Phase I 2012 Department of Health and Human Services
  4. Engineering Microparticles for Taste-Masking and Controlled Release of Pediatric

    Amount: $216,020.00

    DESCRIPTION (provided by applicant): Pediatric drug development presents many unique challenges in the effective treatment of diseases in children, from adequate dosing information and pediatric-speci ...

    SBIR Phase I 2012 Department of Health and Human Services
  5. First Generation of Controlled-Release Bacteriocins/Anti-Microbials

    Amount: $149,216.00

    Combat ration Intermediate Moisture (IM) products use low pH and water content (aw) to discourage bacterial growth. The long-term goal of this proposal is to maintain the microbial stability of ratio ...

    SBIR Phase I 2012 Army Department of Defense
  6. Multi-day Pain Management Therapy with Novel Injectable Formulation

    Amount: $253,678.00

    DESCRIPTION (provided by applicant): Our long term goal is to widespread the use of PPF technology for promoting effective production of drug-encapsulating microparticles with uniform size and physica ...

    SBIR Phase I 2011 Department of Health and Human Services
  7. Expanding Precision Particle Fabrication Technology for the Widespread Control of

    Amount: $695,173.00

    DESCRIPTION (provided by applicant): This overall goal of this project is to develop a scalable process for fabricating oil encapsulated particles with uniform sizes and physical characteristics that ...

    SBIR Phase I 2010 Department of Health and Human Services

Agency Micro-sites

US Flag An Official Website of the United States Government